A capital financing arrangement between Organigram Inc. and a syndicate of investment firms led by Dundee securities closed on August 23rd, 2016. The proceeds of $23M will be used primarily to expand production capacity and acquire new real estate. In addition, a portion of the proceeds will be used to develop commercial scale production, distribution and sales infrastructure for our newly launched cannabis oil program. The full press release can be viewed here.